Research Topics
Species | James Wf CattoSummaryAffiliation: University of Sheffield Country: UK Publications
| Collaborators
|
Detail Information
Publications
Pancreatic debridement in a district general hospital--viable or vulnerable?J W F Catto
Department of Surgery, York District Hospital, UK
Ann R Coll Surg Engl 84:309-13. 2002..This is similar to other previously published rates and the rate from our local tertiary centre. It is concluded that acceptable results for pancreatic debridement are producible in the DGH at economically viable levels...
Targeting chemotherapy to advanced bladder cancer patients most likely to benefitJames Wf Catto
Academic Urology Unit, K Floor, Royal Hallamshire Hospital, Glossop Road, Sheffield, S10 2JF, UK
Future Oncol 6:193-6. 2010..006, without compromising recurrence. The authors conclude that a nomogram-derived 25% risk threshold produced better targeting of chemotherapy than the current standard criteria (mostly using pathological stage)...
The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progressionJames W F Catto
Academic Urology Unit, University of Sheffield, Sheffield, United Kingdom
Eur Urol 57:398-406. 2010..Gene expression microarrays can reveal insights into disease biology and identify novel biomarkers. However, these experiments produce large datasets that are difficult to interpret...
Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladderJames W F Catto
Department of Automatic Control and Systems Engineering, University of Sheffield, Sheffield, UK
Clin Cancer Res 15:3150-5. 2009..We developed a neurofuzzy model (NFM) to predict disease recurrence following RC and PLND in patients who are not usually administered adjuvant chemotherapy...
Behavior of urothelial carcinoma with respect to anatomical locationJ W F Catto
Academic Urology Unit, University of Sheffield, Sheffield, United Kingdom
J Urol 177:1715-20. 2007..Observational studies conflict as to the significance of anatomical location on the behavior of urothelial carcinoma. We compared the biological outcome in a large series of urothelial carcinoma with respect to anatomical location...
MicroRNA in prostate, bladder, and kidney cancer: a systematic reviewJames W F Catto
Institute for Cancer Studies and Academic Urology Unit, University of Sheffield, Sheffield, UK
Eur Urol 59:671-81. 2011..Their altered expression and function have been observed in most urologic cancers. MiRNAs represent potential disease biomarkers and novel therapeutic targets...
The changing face of prostate cancer: can gains in epigenetic knowledge translate into improvements in clinical care?James W F Catto
Academic Urology Unit, K Floor, Royal Hallamshire Hospital, Glossop Road, S10 2JF, Sheffield, UK
J Mol Med 84:883-5. 2006
Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearanceJames W F Catto
Academic Urology Unit, University of Sheffield, Sheffield, United Kingdom
J Urol 175:2323-30. 2006..Tumors with high MSI have numerous DNA mutations, of which many provide no selection benefit. While these tumors represent an ideal model for studying UC clonality, their low frequency has prevented their previous investigation...
Neuro-fuzzy modeling: an accurate and interpretable method for predicting bladder cancer progressionJames W F Catto
Academic Urology Unit, University of Sheffield, Sheffield, United Kingdom
J Urol 175:474-9. 2006..By defuzzification the NFM rule base becomes transparent to overcome the black box nature of ANN...
Simultaneous augmentation cystoplasty is associated with earlier rather than increased artificial urinary sphincter infectionJ W F Catto
Princess Royal Spinal Injuries Unit, Northern General Hospital, Sheffield, United Kingdom
J Urol 173:1237-41. 2005..We reviewed the long-term infective complications of 195 sphincters to investigate for predisposing infective factors and review the role of augmentation cystoplasty...
Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinomaJames W F Catto
Academic Urology Unit, K Floor, Royal Hallamshire Hospital, Glossop Rd, Sheffield, S10 2JF United Kingdom
J Clin Oncol 23:2903-10. 2005..Here we investigate the extent of promoter hypermethylation in TCC throughout the urinary tract...
Distinct patterns of microsatellite instability are seen in tumours of the urinary tractJames W F Catto
The Institute for Cancer Studies, University of Sheffield, UK
Oncogene 22:8699-706. 2003..In addition, we have confirmed that MSI and EMAST are discrete forms of MSI, and that the presence of EMAST does not affect tumour phenotype...
Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instabilityJames W F Catto
Institute for Cancer Studies, Division of Genomic Medicine, University of Sheffield, Sheffield, United Kingdom
Int J Cancer 105:484-90. 2003..Our findings indicate that reduced expression of the MMR proteins may have an important contribution in the development of a subset of TCCs and suggest a potential role for MMR expression as prognostic indicators...
Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin AAaron Leiblich
Section of Oncology, Academic Urology Unit, University of Sheffield, Royal Hallamshire Hospital, Sheffield, UK
Prostate 67:1761-9. 2007..To identify novel candidates associated with metastatic progression, we compared the proteomic profiles of LNCaP (lymph-node metastatic, androgen-dependant) and PC-3 (bone metastatic, androgen-independent), human prostate cancer cells...
Promoter hypermethylation identifies progression risk in bladder cancerDavid R Yates
Institute of Cancer Studies, Academic Urology Unit, Academic Pathology Unit, and Department of Automatic Control and Systems Engineering, The University of Sheffield, Sheffield, United Kingdom
Clin Cancer Res 13:2046-53. 2007..Here, we investigate a panel of methylated loci in a prospectively collected cohort of bladder tumors to determine whether hypermethylation has a useful role in the management of patients with bladder cancer...
Promoter hypermethylation in circulating blood cells identifies prostate cancer progressionMorgan Roupret
Institute for Cancer Studies, University of Sheffield, Royal Hallamshire Hospital, Sheffield, United Kingdom
Int J Cancer 122:952-6. 2008..The extent of this hypermethylation increases during disease progression and can be used to identify the extent and duration of treatment response in prostate cancer...
Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancerIshtiaq Rehman
Academic Urology Unit, Division of Clinical Sciences South, University of Sheffield, United Kingdom, and Service d Urologie, Groupe Hospitalier Pitie Salpetriere, Paris, France
Prostate 65:322-30. 2005..S100A6 and S100A2 are members of the S100 family of calcium binding proteins, which are down regulated in prostate cancer, however the molecular mechanism(s) underlying their loss of expression is unknown...
Less is more: artificial intelligence and gene-expression arraysFreddie C Hamdy
Academic Urology Unit, University of Sheffield, Royal Hallamshire Hospital, Sheffield S10 2 JF, UK
Lancet 364:2003-4. 2004
Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesionsIshtiaq Rehman
Academic Urology Unit, Division of Clinical Sciences South, University of Sheffield, UK
Hum Pathol 35:1385-91. 2004..Our finding of frequent dysregulated expression of S100A11 in cancer and precursor lesions, together with an association with high histological stage, suggests that S100A11 may be involved in prostate cancer development and progression...
DNA methylation and immunohistochemical analysis of the S100A4 calcium binding protein in human prostate cancerIshtiaq Rehman
Academic Urology Unit, Division of Clinical Sciences South, University of Sheffield, Sheffield, UK
Prostate 67:341-7. 2007..The role of DNA methylation in the transcriptional regulation of S100A4 is unknown in human prostate cancer...
A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysisMorgan Roupret
Institute for Cancer Studies and Academic Urology Unit, University of Sheffield, Royal Hallamshire Hospital, UK
BJU Int 101:1448-53. 2008....
iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progressionAdam Glen
Academic Urology Unit, Section of Oncology, University of Sheffield, Floor K, Royal Hallamshire Hospital, Glossop Road, Sheffield, S10 2JF, UK
J Proteome Res 7:897-907. 2008..0005, Mann-Whitney U). Our study is the first to report the application of iTRAQ technology and its potential for the global proteomic profiling of prostate cancer cells, including the identification of absent protein expression...
Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networksJames W F Catto
The Academic Urology Unit, Department of Automatic Control and Systems Engineering, University of Sheffield, Sheffield S10 2JF, United Kingdom
Clin Cancer Res 9:4172-7. 2003..This technique could be used widely in a variety of areas of medicine...
Distinct microRNA alterations characterize high- and low-grade bladder cancerJames W F Catto
Academic Urology Unit, University of Sheffield, Sheffield, United Kingdom
Cancer Res 69:8472-81. 2009..In conclusion, distinct microRNA alterations characterize UCC and target genes in a pathway-specific manner. These data reveal new insights into the disease biology and have implications regarding tumor diagnosis, prognosis and therapy...
Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massageMorgan Roupret
Institute for Cancer Studies and Academic Urology Unit, University of Sheffield, Royal Hallamshire Hospital, Sheffield, UK
Clin Cancer Res 13:1720-5. 2007..Many patients require repeat prostate biopsies to diagnose the disease. We investigated whether aberrant promoter hypermethylation in prostatic fluid could reliably detect prostate cancer...
Clinically localised prostate cancer is microsatellite stableAbdel Rahmene Azzouzi
Service d Urologie, CHU d Angers, Centre de Recherche pour les Pathologies Protatiques, Universite Paris VII, Paris, France, and Department of Pathology, Royal Hallamshire Hospital, Sheffield, UK
BJU Int 99:1031-5. 2007..To determine the frequency of microsatellite instability (MSI) change with mono-, di- and tetranucleotide markers in clinically localized prostate cancer, and to correlate those markers with clinical and pathological variables...
More nomograms or better evidence of efficacy: what do we need in urologic oncology?James W F Catto
Eur Urol 54:11-2. 2008
Application of artificial intelligence to the management of urological cancerMaysam F Abbod
School of Engineering and Design, Brunel University, West London, United Kingdom
J Urol 178:1150-6. 2007..We reviewed the basic concepts behind artificial intelligence techniques and explored the applications of this new dynamic technology in various aspects of urological cancer management...
